Cargando…
Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
Tumor resistance to apoptosis is one the main causes of anticancer treatment failure. Previous studies showed that LMW‐PTP overexpression enhances resistance of cancer cells to traditional anticancer drugs. Today, the role of LMW‐PTP in inducing resistance to apoptosis in melanoma cells remains to b...
Autores principales: | Lori, Giulia, Paoli, Paolo, Caselli, Anna, Cirri, Paolo, Marzocchini, Riccardo, Mangoni, Monica, Talamonti, Cinzia, Livi, Lorenzo, Raugei, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943542/ https://www.ncbi.nlm.nih.gov/pubmed/29573568 http://dx.doi.org/10.1002/cam4.1435 |
Ejemplares similares
-
LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
por: Capitani, Nagaja, et al.
Publicado: (2019) -
Computational and structure-guided design of phosphoinositide substrate specificity into the tyrosine specific LMW-PTP enzyme
por: Egbe, Eyong, et al.
Publicado: (2020) -
Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins
por: Ferreira, Paula A., et al.
Publicado: (2012) -
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)
por: Bonomo, Pierluigi, et al.
Publicado: (2018) -
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
por: Pardella, Elisa, et al.
Publicado: (2020)